T1c prostate cancer detection rate and pathologic characteristics: Comparison between patients with serum prostate-specific antigen range of 3.0 to 4.0 ng/mL and 4.1 to 10.0 ng/mL in Korean population

Urology

Volumn 68, Issue 1, 2006, Pages 85-88

  Park, Hyoung Keun ^a   Hong, Sung Kyu ^b   Byun, Seok Soo ^b   Lee, Sang Eun ^b  

^a Dongguk University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER STAGING; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DIGITAL RECTAL EXAMINATION; EVALUATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

BIOPSY, NEEDLE; DIGITAL RECTAL EXAMINATION; HUMANS; KOREA; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33745822091     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.01.067     Document Type: Article

References (10)

1. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 350 (2004) 2239-2246
2. Catalona W.J., Smith D.S., and Ornstein D.K. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 14 (1997) 1452-1455
3. Babaian R.J., Fritsche H., Ayala A., et al. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL. Urology 56 (2000) 1000-1006
4. Smith D.S., Carvalhal G.F., Mager D.E., et al. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol 160 (1998) 1734-1738
5. Schroder F.H., Roobol-Bouts M., Vis A.N., et al. Prostate-specific antigen-based early detection of prostate cancer validation of screening without rectal examination. Urology 57 (2001) 83-90
6. Kobayashi T., Nishizawa K., Ogura K., et al. Detection of prostate cancer in men with prostate-specific antigen levels of 2.0 to 4.0 ng/mL equivalent to that in men with 4.1 to 10.0 ng/mL in a Japanese population. Urology 63 (2004) 727-731
7. Schroder F.H., van der Cruijsen-Koeter I., de Koning H.J., et al. Prostate cancer detection at low prostate specific antigen. J Urol 163 (2000) 806-812
8. Allan R.W., Sanderson H., and Epstein J.I. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen. role of prostate specific antigen density. J Urol 170 (2003) 370-372
9. Song J.M., Kim C.B., Chung H.C., et al. Prostate-specific antigen, digital rectal examination and transrectal ultrasonography. a meta-analysis for this diagnostic triad of prostate cancer in symptomatic Korean men. Yonsei Med J 46 (2005) 414-424
10. Onur R., Littrup P.J., Pontes J.E., et al. Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol 172 (2004) 512-514